This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Therapeutic Drug Monitoring Market

Market Insights on Therapeutic Drug Monitoring covering sales outlook, demand forecast & up-to-date key trends

Therapeutic Drug Monitoring Market by Type, Technology & Region - Forecast 2022 - 2032

Therapeutic Drug Monitoring Market Overview (2022-2032)

[250 Pages Report] The therapeutic drug monitoring market is projected to record a CAGR of 9.7% during the forecast period, up from US$ 1.5 Bn in 2020 to reach a valuation of US$ 2.9 Bn by 2026.

Report Attribute

Details

Estimated Base Year Value (2020)

US$ 1.5 Bn

Expected Market Value (2026)

US$ 2.9 Bn

Projected Growth Rate (2022-2032)

9.7%

Sales of therapeutic drug monitoring are expected to rise as organ transplant surgeries are also increasing. In addition to this, demand for therapeutic drug monitoring is rising on account of the rising preference for precision medicine.

Increasing research and development in the industry is also projected to contribute to the growth of the therapeutic drug monitoring market share.

Some of the key therapeutic drug monitoring market trends promoting the demand for therapeutic drug monitoring include precision medicine, a growing field of disease treatment and prevention that considers individual differences in genes, surroundings, and lifestyles.

Precision medicine picks treatments that are completely suited to a patient's ailment and medical history. Oncology has experienced the most development, although this technique extends into all disease areas.

Cancer patients are being treated with a combination of medications based on studies of the patient's factors such as systems biology, tumor analysis, and gene expression data in the absence and presence of pharmacological disruption.

This method, which is now being tried in various situations, intends to transform pharmacotherapy in oncology and other disease areas. Therapeutic drug monitoring has the potential to make a significant contribution to the advancement of this unique approach to patient care.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Growth Propellers to the Therapeutic Drug Monitoring Market Share?

Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. Therapeutic drug monitoring aims to refine patient care by individually adjusting the drug dosage for better outcomes.

The global therapeutic drug monitoring market showed significant growth over the last few years and is projected to grow at a robust CAGR during the forecast period.

The sales of therapeutic drug monitoring are driven by various key factors, including an ageing population with better health care services, increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring markets, rise in drug profiling.

There are ongoing problems with reimbursement, reduction in the hospital fields, and a weak global economy. In addition, fluctuating exchange rates further weakens the sales of therapeutic drug monitoring.

With the advancement of technology and increased incidence in the disease population, demand for therapeutic drug monitoring is rising by gaining wide acceptance as a method of choice among patients.

As a result, the sales of therapeutic drug monitoring are expected to grow at a healthy CAGR in the forecast period.

In the upcoming years, the demand for therapeutic drug monitoring will undergo a significant rise. The convergence will make these alterations of new and more stringent regulations improvements in diagnostic technologies, automation, and system engineering.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Region holds the Highest Growth Potential in the Therapeutic Drug Monitoring Market?

Depending on geographic regions, the therapeutic drug monitoring market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

In terms of geography, North America dominates the sales of therapeutic drug monitoring, followed by Europe. During the earlier stages, market development growth rates were higher, while the market value was relatively low. The demand for therapeutic drug monitoring was growing. 

As the market value and the sales of therapeutic drug monitoring started to rise, the annual growth rate declined slightly but is expected to increase again as the market develops and the advantages of therapeutic drug monitoring get appreciated in the established markets and as the techniques and products appear in the emerging market. In addition, the emerging economies have also started showing a positive inclination as the demand for therapeutic drug monitoring increases.

How is the Competitive Landscape in the Therapeutic Drug Monitoring Market?

The therapeutic drug monitoring market is currently led by Coulter, BioChem Pharmaceuticals, BioRad, OraSure Technologies, and Roche Diagnostics. 

To combat the rising demand for therapeutic drug monitoring, Thermo Fisher Scientific (US) and Mindray collaborated on Clinical Chemistry Analyzers for Drugs of Abuse Immunoassays in 2021. 

F. Hoffmann-La Roche (Switzerland) announced in 2020 that new diagnostics would be built in South Africa, including labs, biotech production, and office space. To improve its diagnostics offerings and increase the sales of therapeutic drug monitoring.

Implementing a personalized therapeutic drug monitoring (TDM) strategy at the time of infliximab beginning does not increase remission rates in patients with various inflammatory illnesses. As a result, companies are increasing their research to improve their sales of therapeutic drug monitoring.

The report comprises key players contributing to the therapeutic drug monitoring market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyses the competitive landscape and therapeutic drug monitoring market share acquired by players to strengthen their market position.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope Of Report

Report Attribute

Details

Growth rate

CAGR of 9.7% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,

Segments covered

Type, technology, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

Roche Diagnostics, Coulter, BioRad, OraSure Technologies, and BioChem Pharmaceuticals.

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Key Segments

By Type:

  • Antibiotics
  • Anticonvulsants
  • Antiarrhythmic
  • Antineoplastic
  • Bronchodilators
  • Immunosuppressive
  • HIV/AIDS Drugs

By Technology:

  • Spectrometry
  • Chromatography
  • Electrophoresis
  • Proteomic Technology

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The therapeutic drug monitoring market is predicted to register a CAGR of 9.7% during the forecast period.

Key players holding substantial therapeutic drug monitoring market share include Roche Diagnostics, Coulter, BioRad, OraSure Technologies, and BioChem Pharmaceuticals.

As per the analysis, the therapeutic drug monitoring market share is likely to be US$ 2.9 Bn by 2026.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Analyte

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Analyte, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Analyte, 2022-2032

        5.3.1. Analgesics

        5.3.2. Antifungal

        5.3.3. Antibiotics

        5.3.4. Antiepileptic

        5.3.5. Antineoplastic & Cancer Chemotherapy

        5.3.6. Antiretroviral/Anti-HIV Drugs

        5.3.7. Analeptics & Bronchodilators

        5.3.8. Anti-arrhythmic Drugs

        5.3.9. Antihypertensive

        5.3.10. Immunosuppressive Agents

        5.3.11. Psychoactive Agents

        5.3.12. Addiction Therapeutics

        5.3.13. Antihypertensive

        5.3.14. Hormones

        5.3.15. Anticoagulants

        5.3.16. Antilipidemic

        5.3.17. Alzheimer’s Therapeutics

    5.4. Y-o-Y Growth Trend Analysis By Analyte, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Analyte, 2022-2032

-dive segmentation will be available in the sample on request

6. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Technique

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Technique, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Technique, 2022-2032

        6.3.1. Immunoassay

        6.3.2. Mass Spectrometry

        6.3.3. Other Techniques

    6.4. Y-o-Y Growth Trend Analysis By Technique, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Technique, 2022-2032

-dive segmentation will be available in the sample on request

7. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia & Pacific

        7.3.6. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Analyte

        8.2.3. By Technique

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Analyte

        8.3.3. By Technique

    8.4. Key Takeaways

9. Latin America Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Analyte

        9.2.3. By Technique

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Analyte

        9.3.3. By Technique

    9.4. Key Takeaways

10. Europe Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Analyte

        10.2.3. By Technique

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Analyte

        10.3.3. By Technique

    10.4. Key Takeaways

11. East Asia Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Analyte

        11.2.3. By Technique

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Analyte

        11.3.3. By Technique

    11.4. Key Takeaways

12. South Asia & Pacific Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Indonesia

            12.2.1.4. Malaysia

            12.2.1.5. Singapore

            12.2.1.6. Australia

            12.2.1.7. New Zealand

            12.2.1.8. Rest of South Asia & Pacific

        12.2.2. By Analyte

        12.2.3. By Technique

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Analyte

        12.3.3. By Technique

    12.4. Key Takeaways

13. MEA Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Analyte

        13.2.3. By Technique

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Analyte

        13.3.3. By Technique

    13.4. Key Takeaways

14. Key Countries Therapeutic Drug Monitoring Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Analyte

            14.1.2.2. By Technique

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Analyte

            14.2.2.2. By Technique

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Analyte

            14.3.2.2. By Technique

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Analyte

            14.4.2.2. By Technique

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Analyte

            14.5.2.2. By Technique

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Analyte

            14.6.2.2. By Technique

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Analyte

            14.7.2.2. By Technique

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Analyte

            14.8.2.2. By Technique

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Analyte

            14.9.2.2. By Technique

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Analyte

            14.10.2.2. By Technique

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Analyte

            14.11.2.2. By Technique

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Analyte

            14.12.2.2. By Technique

    14.13. India

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Analyte

            14.13.2.2. By Technique

    14.14. Thailand

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Analyte

            14.14.2.2. By Technique

    14.15. Indonesia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Analyte

            14.15.2.2. By Technique

    14.16. Malaysia

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Analyte

            14.16.2.2. By Technique

    14.17. Singapore

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Analyte

            14.17.2.2. By Technique

    14.18. Australia

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Analyte

            14.18.2.2. By Technique

    14.19. New Zealand

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Analyte

            14.19.2.2. By Technique

    14.20. GCC Countries

        14.20.1. Pricing Analysis

        14.20.2. Market Share Analysis, 2021

            14.20.2.1. By Analyte

            14.20.2.2. By Technique

    14.21. South Africa

        14.21.1. Pricing Analysis

        14.21.2. Market Share Analysis, 2021

            14.21.2.1. By Analyte

            14.21.2.2. By Technique

    14.22. Israel

        14.22.1. Pricing Analysis

        14.22.2. Market Share Analysis, 2021

            14.22.2.1. By Analyte

            14.22.2.2. By Technique

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Analyte

        15.3.3. By Technique

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Thermo Fisher Scientific Inc.

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

                16.1.1.5.2. Product Strategy

                16.1.1.5.3. Channel Strategy

        16.1.2. Abbott

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

                16.1.2.5.2. Product Strategy

                16.1.2.5.3. Channel Strategy

        16.1.3. Roche Diagnostics

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

                16.1.3.5.2. Product Strategy

                16.1.3.5.3. Channel Strategy

        16.1.4. Bio-Rad Laboratories

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

                16.1.4.5.2. Product Strategy

                16.1.4.5.3. Channel Strategy

        16.1.5. Sigma-Aldrich

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

                16.1.5.5.2. Product Strategy

                16.1.5.5.3. Channel Strategy

        16.1.6. Beckman Coulter, Inc.

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

                16.1.6.5.2. Product Strategy

                16.1.6.5.3. Channel Strategy

        16.1.7. Randox Laboratories Ltd.

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

                16.1.7.5.2. Product Strategy

                16.1.7.5.3. Channel Strategy

        16.1.8. SEKISUI MEDICAL CO., LTD.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

                16.1.8.5.2. Product Strategy

                16.1.8.5.3. Channel Strategy

        16.1.9. Chromsystems Instruments & Chemicals GmbH

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

                16.1.9.5.2. Product Strategy

                16.1.9.5.3. Channel Strategy

        16.1.10. SJK Global, LLC.

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

                16.1.10.5.2. Product Strategy

                16.1.10.5.3. Channel Strategy

        16.1.11. Alpha Laboratories

            16.1.11.1. Overview

            16.1.11.2. Product Portfolio

            16.1.11.3. Profitability by Market Segments

            16.1.11.4. Sales Footprint

            16.1.11.5. Strategy Overview

                16.1.11.5.1. Marketing Strategy

                16.1.11.5.2. Product Strategy

                16.1.11.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Region, 2017-2032

Table 3: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 4: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 5: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 6: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Table 7: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032

Table 9: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 10: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 11: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 12: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Table 13: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032

Table 15: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 16: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 17: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 18: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Table 19: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 20: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032

Table 21: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 22: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 23: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 24: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Table 25: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032

Table 27: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 28: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 29: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 30: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Table 31: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 32: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032

Table 33: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 34: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 35: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 36: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Table 37: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 38: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032

Table 39: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032

Table 40: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032

Table 41: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032

Table 42: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 2: Global Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 3: Global Therapeutic Drug Monitoring Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Region, 2017-2032

Figure 6: Global Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 9: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 10: Global Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 11: Global Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 12: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 13: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 14: Global Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 15: Global Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 16: Global Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 17: Global Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 18: Global Therapeutic Drug Monitoring Market Attractiveness by Region, 2022-2032

Figure 19: North America Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 20: North America Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 21: North America Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032

Figure 22: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 23: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032

Figure 24: North America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 25: North America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 26: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 27: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 28: North America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 29: North America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 30: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 31: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 32: North America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 33: North America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 34: North America Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 35: North America Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 36: North America Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032

Figure 37: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 38: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 39: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032

Figure 40: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 41: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032

Figure 42: Latin America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 43: Latin America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 44: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 45: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 46: Latin America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 47: Latin America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 48: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 49: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 50: Latin America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 51: Latin America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 52: Latin America Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 53: Latin America Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 54: Latin America Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032

Figure 55: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 56: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 57: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032

Figure 58: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 59: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032

Figure 60: Europe Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 61: Europe Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 62: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 63: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 64: Europe Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 65: Europe Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 66: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 67: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 68: Europe Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 69: Europe Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 70: Europe Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 71: Europe Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 72: Europe Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032

Figure 73: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 74: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 75: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032

Figure 76: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 77: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032

Figure 78: East Asia Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 79: East Asia Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 80: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 81: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 82: East Asia Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 83: East Asia Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 84: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 85: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 86: East Asia Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 87: East Asia Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 88: East Asia Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 89: East Asia Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 90: East Asia Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032

Figure 91: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 92: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 93: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032

Figure 94: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 95: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032

Figure 96: South Asia & Pacific Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 97: South Asia & Pacific Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 98: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 99: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 100: South Asia & Pacific Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 101: South Asia & Pacific Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 102: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 103: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 104: South Asia & Pacific Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 105: South Asia & Pacific Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 106: South Asia & Pacific Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 107: South Asia & Pacific Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 108: South Asia & Pacific Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032

Figure 109: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032

Figure 110: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032

Figure 111: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032

Figure 112: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 113: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032

Figure 114: MEA Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 115: MEA Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 116: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032

Figure 117: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032

Figure 118: MEA Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032

Figure 119: MEA Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032

Figure 120: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032

Figure 121: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032

Figure 122: MEA Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032

Figure 123: MEA Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032

Figure 124: MEA Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032

Figure 125: MEA Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032

Figure 126: MEA Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Therapeutic Drug Monitoring Market